Detection of GFAP and D‐Dimer in a Point‐of‐Care Test for Large Vessel Occlusion Ischemic Stroke

Detection of GFAP and D‐Dimer in a Point‐of‐Care Test for Large Vessel Occlusion Ischemic Stroke

Background The blood biomarkers GFAP (glial fibrillary acidic protein)  and D‐dimer have been shown to accurately diagnose large vessel occlusion ischemic stroke. The Upfront DX LVOne is a novel lateral flow‐based point‐of‐care test used for the detection of GFAP and D‐dimer. This study sought to (1...

Full description

Saved in:
Bibliographic Details
Main Authors: Edoardo Gaude, Danielle Murphy, Jakob V.E. Gerstl, Ari D. Kappel, Adam A. Dmytriw, Noah L.A. Nawabi, Saef Izzy, Rodolfo E. Alcedo Guardia, Juan C. Vicenty‐Padilla, Toby Gropen, Nirav J. Patel, David S. Liebeskind, Adnan H. Siddiqui, Alfred Pokmeng See, Mohammed A. Aziz‐Sultan, Joshua D. Bernstock
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:Stroke: Vascular and Interventional Neurology
Subjects:
biomarkers
D‐dimer
glial fibrillary acidic protein
large vessel occlusion
point of care diagnostics
prehospital triage
Online Access:https://www.ahajournals.org/doi/10.1161/SVIN.124.001559
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items